Old | New | Differences | |
---|---|---|---|
1 | 1 | By: Zwiener H.B. No. 4145 | |
2 | 2 | ||
3 | 3 | ||
4 | 4 | A BILL TO BE ENTITLED | |
5 | 5 | AN ACT | |
6 | 6 | relating to the prescription of a controlled substance to certain | |
7 | 7 | patients for the treatment of pain. | |
8 | 8 | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
9 | 9 | SECTION 1. Subchapter C, Chapter 481, Health and Safety | |
10 | 10 | Code, is amended by adding Section 481.0725 to read as follows: | |
11 | 11 | Sec. 481.0725. PRESCRIPTION OF CONTROLLED SUBSTANCE AFTER | |
12 | 12 | DRUG TEST. A practitioner may not refuse to prescribe a controlled | |
13 | 13 | substance for the treatment of pain to a patient solely because the | |
14 | 14 | results of a drug test taken by the patient indicated that | |
15 | 15 | tetrahydrocannabinol or cannabidiol was present in the patient's | |
16 | 16 | body, or refuse to continue to treat the patient. | |
17 | 17 | SECTION 2. The change in law made by this Act applies only | |
18 | 18 | to a prescription issued on or after the effective date of this Act. | |
19 | 19 | A prescription issued before the effective date of this Act is | |
20 | 20 | governed by the law in effect on the date the prescription is | |
21 | 21 | issued, and the former law is continued in effect for that purpose. | |
22 | 22 | SECTION 3. This Act takes effect September 1, 2019. |